Flu Testing Fuels Revenue Growth in Roche's PCR, Purification Business This Year

A Roche official said that a "very substantial" portion of the 24 percent growth in qPCR and NAP systems could be attributed to H1N1, with the largest growth in instruments.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories